# Waters (WAT) — Earnings

WAT · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/wat/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jul 4, 2026 |
| EPS actual | $3.05 |
| EPS estimate | $3.01 |
| EPS surprise | +1.32% |
| Revenue surprise | +1.40% |
| Revenue | $1.6B |
| Revenue estimate | $1.6B |
| Reported | Aug 4, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1000697/000119312526344691/d170082d10q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/ea3360e6-6837-2b29-1b51-974e811fe79c.html) |

Waters reported Q2 2026 results on August 4, 2026. Earnings per share came in at $3.05, ahead of the $3.01 estimate by 1.32%. Revenue was $1.6 billion, 1.40% above the consensus estimate. Compared with Q2 2025, EPS rose about 3% from $2.95, while revenue was roughly double the $771.3 million of a year earlier.

Revenue is the biggest change in the table. Through 2025, quarterly revenue stayed between about $637 million and $932 million. It rose to $1.3 billion in Q1 2026 and $1.6 billion in Q2 2026, the highest here. EPS grew far less: the first half of 2026 adds up to $5.75 per share, about 11% more than a year earlier. Annual EPS hovered near $12 from 2022 to 2024, then rose about 11% to $13.13 in 2025. The fourth quarter has been the strongest of each year, and Q4 2025 set the EPS high at $4.53. Waters beat the EPS estimate in 19 of the last 20 quarters, missing only in Q1 2023.

Waters reported Q3 between November 1 and November 7 in each of the past five years. That points to early November 2026 for the next report. It will show whether revenue holds at the higher level.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 4, 2026 | $3.01 | $3.05 | 1.32% | $1.6B | $1.6B |
| Q1 2026 | May 5, 2026 | $2.31 | $2.70 | 17.06% | $1.2B | $1.3B |
| Q4 2025 | Feb 9, 2026 | $4.51 | $4.53 | 0.45% | $928.3M | $932.4M |
| Q3 2025 | Nov 4, 2025 | $3.21 | $3.40 | 5.99% | $781.0M | $799.9M |
| Q2 2025 | Aug 4, 2025 | $2.94 | $2.95 | 0.32% | $748.7M | $771.3M |
| Q1 2025 | May 6, 2025 | $2.22 | $2.25 | 1.24% | $654.8M | $661.7M |
| Q4 2024 | Feb 12, 2025 | $4.03 | $4.10 | 1.70% | $857.1M | $872.7M |
| Q3 2024 | Nov 1, 2024 | $2.68 | $2.93 | 9.45% | $713.0M | $740.3M |
| Q2 2024 | Jul 31, 2024 | $2.57 | $2.63 | 2.21% | $700.1M | $708.5M |
| Q1 2024 | May 7, 2024 | $2.09 | $2.21 | 5.53% | $635.6M | $636.8M |
| Q4 2023 | Feb 6, 2024 | $3.55 | $3.62 | 1.86% | $815.5M | $819.5M |
| Q3 2023 | Nov 7, 2023 | $2.55 | $2.84 | 11.38% | $722.3M | $711.7M |
| Q2 2023 | Aug 2, 2023 | $2.59 | $2.80 | 8.27% | $733.4M | $740.6M |
| Q1 2023 | May 9, 2023 | $2.62 | $2.49 | -5.06% | $697.9M | $684.7M |
| Q4 2022 | Feb 15, 2023 | $3.74 | $3.84 | 2.69% | $833.2M | $858.5M |
| Q3 2022 | Nov 1, 2022 | $2.58 | $2.64 | 2.39% | $680.1M | $708.6M |
| Q2 2022 | Aug 2, 2022 | $2.66 | $2.75 | 3.23% | $707.5M | $714.3M |
| Q1 2022 | May 3, 2022 | $2.33 | $2.80 | 20.02% | $634.1M | $690.6M |
| Q4 2021 | Feb 1, 2022 | $3.48 | $3.67 | 5.37% | $820.8M | $836.4M |
| Q3 2021 | Nov 2, 2021 | $2.36 | $2.66 | 12.84% | $654.6M | $659.2M |

## Frequently Asked Questions

### When did Waters (WAT) last report earnings?

Waters last reported on Aug 4, 2026, covering fiscal Q2 2026.

### Did WAT beat earnings estimates?

Yes. Waters reported EPS of $3.05 for Q2 2026 against a $3.01 estimate — a 1.32% beat.

### How much revenue did WAT report last quarter?

Waters reported $1.6B in revenue for Q2 2026, against a consensus estimate of $1.6B.

## Similar Stocks

- [A](https://www.lighthorse.io/tickers/a) — Agilent Technologies, Inc. Common Stock
- [MTD](https://www.lighthorse.io/tickers/mtd) — Mettler-Toledo International, Inc. Common Stock
- [TMO](https://www.lighthorse.io/tickers/tmo) — Thermo Fisher Scientific Inc Common Stock
- [RVTY](https://www.lighthorse.io/tickers/rvty) — Revvity, Inc. Common Stock
- [BRKR](https://www.lighthorse.io/tickers/brkr) — Bruker Corporation - Common Stock
- [TECH](https://www.lighthorse.io/tickers/tech) — Bio-Techne Corp - Common Stock
- [DHR](https://www.lighthorse.io/tickers/dhr) — Danaher Corporation Common Stock
- [IQV](https://www.lighthorse.io/tickers/iqv) — IQVIA Holdings, Inc. Common Stock
- [RGEN](https://www.lighthorse.io/tickers/rgen) — Repligen Corporation - Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).